These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25053509)

  • 1. Soluble MHC-II proteins promote suppressive activity in CD4+ T cells.
    Bakela K; Kountourakis N; Aivaliotis M; Athanassakis I
    Immunology; 2015 Jan; 144(1):158-69. PubMed ID: 25053509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting edge: primary B lymphocytes preferentially expand allogeneic FoxP3+ CD4 T cells.
    Chen X; Jensen PE
    J Immunol; 2007 Aug; 179(4):2046-50. PubMed ID: 17675460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble MHC class II-driven therapy for a systemic lupus erythematosus murine experimental in vitro and in vivo model.
    Bakela K; Dimakopoulou M; Batsou P; Manidakis N; Athanassakis I
    Scand J Immunol; 2018 Mar; 87(3):. PubMed ID: 29412476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of antigen-binding and MHC class II-bearing T cells with suppressive activity in response to tolerogenic stimulus.
    Vevis K; Matheakakis A; Kyvelidou C; Bakela K; Athanassakis I
    Immunobiology; 2012 Jan; 217(1):100-10. PubMed ID: 21840082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered T-cell receptor + CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-beta-treated alloreactive T cells that do not induce graft-versus-host disease.
    Boussiotis VA; Chen ZM; Zeller JC; Murphy WJ; Berezovskaya A; Narula S; Roncarolo MG; Blazar BR
    Blood; 2001 Jan; 97(2):565-71. PubMed ID: 11154238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered proximal T-cell receptor signalling events in mouse CD4+ T cells in the presence of anti-CD4 monoclonal antibodies: evidence for reduced phosphorylation of Zap-70 and LAT.
    Pullar CE; Morris PJ; Wood KJ
    Scand J Immunol; 2003 Apr; 57(4):333-41. PubMed ID: 12662296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of the LAT adaptor converts antigen-responsive T cells into pathogenic effectors that function independently of the T cell receptor.
    Mingueneau M; Roncagalli R; Grégoire C; Kissenpfennig A; Miazek A; Archambaud C; Wang Y; Perrin P; Bertosio E; Sansoni A; Richelme S; Locksley RM; Aguado E; Malissen M; Malissen B
    Immunity; 2009 Aug; 31(2):197-208. PubMed ID: 19682930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
    Shen X; Niu C; König R
    Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-specific signaling by a soluble, dimeric peptide/major histocompatibility complex class II/Fc chimera leading to T helper cell type 2 differentiation.
    Casares S; Zong CS; Radu DL; Miller A; Bona CA; Brumeanu TD
    J Exp Med; 1999 Aug; 190(4):543-53. PubMed ID: 10449525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of CD25-positive T cells during syngeneic pregnancy: production of stimulatory class II MHC molecules.
    Kyvelidou C; Chatzi K; Semitekolou M; Papathanassiou X; Vassiliadis S; Athanassakis I
    Scand J Immunol; 2009 Dec; 70(6):584-95. PubMed ID: 19906201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LAT polices T cell activation.
    Brownlie R; Zamoyska R
    Immunity; 2009 Aug; 31(2):174-6. PubMed ID: 19699166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal development and activation but altered cytokine production of Fyn-deficient CD4+ T cells.
    Mamchak AA; Sullivan BM; Hou B; Lee LM; Gilden JK; Krummel MF; Locksley RM; DeFranco AL
    J Immunol; 2008 Oct; 181(8):5374-85. PubMed ID: 18832694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of CD4 T cell function by soluble MHC II-peptide chimeras.
    Casares S; Bona CA; Brumeanu TD
    Int Rev Immunol; 2001 Oct; 20(5):547-73. PubMed ID: 11890612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perturbation of naive TCR transgenic T cell functional responses and upstream activation events by anti-CD4 monoclonal antibodies.
    Fehérvári Z; Cooke A; Brett S; Turner J
    Eur J Immunol; 2002 Feb; 32(2):333-40. PubMed ID: 11807772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen, in the presence of TGF-beta, induces up-regulation of FoxP3gfp+ in CD4+ TCR transgenic T cells that mediate linked suppression of CD8+ T cell responses.
    Kapp JA; Honjo K; Kapp LM; Goldsmith K; Bucy RP
    J Immunol; 2007 Aug; 179(4):2105-14. PubMed ID: 17675469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.
    Pletinckx K; Vaeth M; Schneider T; Beyersdorf N; Hünig T; Berberich-Siebelt F; Lutz MB
    Eur J Immunol; 2015 Feb; 45(2):480-91. PubMed ID: 25382658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration.
    Zhang X; Izikson L; Liu L; Weiner HL
    J Immunol; 2001 Oct; 167(8):4245-53. PubMed ID: 11591746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LAT-mediated signaling in CD4+CD25+ regulatory T cell development.
    Koonpaew S; Shen S; Flowers L; Zhang W
    J Exp Med; 2006 Jan; 203(1):119-29. PubMed ID: 16380508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis.
    Sellebjerg F; Krakauer M; Khademi M; Olsson T; Sørensen PS
    Clin Exp Immunol; 2012 Nov; 170(2):149-55. PubMed ID: 23039885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.